Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Microbiol. 2008 Jan;6(1):17-27.

    The biology and future prospects of antivirulence therapies.

    Source

    Department of Molecular Microbiology, Washington University, Saint Louis, Missouri 63110, USA.

    Erratum in

    • Nat Rev Microbiol. 2009 Nov;7(11):836.

    Abstract

    The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches. Targeting bacterial virulence is an alternative approach to antimicrobial therapy that offers promising opportunities to inhibit pathogenesis and its consequences without placing immediate life-or-death pressure on the target bacterium. Certain virulence factors have been shown to be potential targets for drug design and therapeutic intervention, whereas new insights are crucial for exploiting others. Targeting virulence represents a new paradigm to empower the clinician to prevent and treat infectious diseases.

    PMID:
    18079741
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2211378
    Free PMC Article

    Images from this publication.See all images (4) Free text

    Figure 2
    Figure 4
    Figure 1
    Figure 3

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk